Salvati, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 884
EU - Europa 572
AS - Asia 132
Totale 1.588
Nazione #
US - Stati Uniti d'America 883
PL - Polonia 371
SE - Svezia 77
CN - Cina 67
IT - Italia 30
VN - Vietnam 27
IE - Irlanda 22
DE - Germania 21
SG - Singapore 19
GB - Regno Unito 17
RU - Federazione Russa 12
AT - Austria 10
TR - Turchia 6
HK - Hong Kong 5
IN - India 5
UA - Ucraina 4
FR - Francia 3
FI - Finlandia 2
IR - Iran 2
GR - Grecia 1
KR - Corea 1
NO - Norvegia 1
PA - Panama 1
RO - Romania 1
Totale 1.588
Città #
Warsaw 368
Fairfield 148
Chandler 97
Seattle 85
Woodbridge 79
Wilmington 59
Ashburn 58
Houston 54
Cambridge 50
Redmond 35
Dong Ket 27
Ann Arbor 22
Dublin 22
Dearborn 16
Nanjing 14
Rome 14
San Diego 14
San Mateo 14
Bremen 13
Princeton 13
Guangzhou 10
Jacksonville 10
Vienna 10
Boston 9
Moscow 7
Singapore 7
Izmir 6
Hong Kong 5
London 5
Phoenix 5
Andover 4
Augusta 4
Cattolica 4
Nanchang 4
Acton 3
Hangzhou 3
Marseille 3
Radoslaw 3
Beijing 2
Chiswick 2
Edinburgh 2
Helsinki 2
Jiaxing 2
Jinan 2
Kish 2
Kunming 2
Milan 2
Mountain View 2
Norwalk 2
Shenyang 2
Tianjin 2
Athens 1
Atlanta 1
Boardman 1
Bucharest 1
Caserta 1
Changsha 1
Chicago 1
Colleferro 1
Fuzhou 1
Gangseo-gu 1
Hebei 1
Huddinge 1
Islington 1
Lanzhou 1
Marcianise 1
Nagold 1
New Bedfont 1
Orange 1
Padova 1
Redwood City 1
Ruvo Di Puglia 1
Totale 1.351
Nome #
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer 253
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer 251
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells. 243
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 242
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 229
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells 73
EGFR Inhibition Abrogates Leiomyosarcoma Cell Chemoresistance through Inactivation of Survival Pathways and Impairment of CSC Potential 67
EGFR Inhibition Abrogates Leiomyosarcoma Cell Chemoresistance through Inactivation of Survival Pathways and Impairment of CSC Potential 60
Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts 54
Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts 42
Theratyping cystic fibrosis in vitro in ALI culture and organoid models generated from patient-derived nasal epithelial conditionally reprogrammed stem cells 37
A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells 30
A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors 29
Totale 1.610
Categoria #
all - tutte 5.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020524 0 0 79 179 29 47 54 28 40 18 40 10
2020/2021246 18 20 22 10 38 10 56 3 19 12 9 29
2021/2022145 18 23 4 4 8 9 6 25 4 11 22 11
2022/2023252 25 38 16 37 20 35 5 20 41 4 6 5
2023/2024100 5 36 4 7 2 2 3 1 3 2 21 14
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 1.610